+
+
Stay Informed
SURGICAL VALVE SOLUTIONS

REGENT™ AND MASTERS SERIES MECHANICAL HEART VALVES

Lasting durability, excellent hemodynamics, and designed to meet diverse patient needs with precision and reliability.

SURGICAL VALVE SOLUTIONS

REGENT™ AND MASTERS SERIES MECHANICAL HEART VALVES

Lasting durability, excellent hemodynamics, and designed to meet diverse patient needs with precision and reliability.

TRUSTED FOR GENERATIONS

As the original bi-leaflet mechanical heart valve, Abbott has earned the trust of physicians and patients for generations. But we don't live in the past, and neither do you nor your patients. Our mechanical heart valves are meticulously engineered with a deep understanding of the complexities that go into creating a durable valve. Today we are still offering excellent outcomes for everyone from pediatric patients to adults.

The most implanted valve in the world

3.5+ MILLION
PATIENTS
treated with Abbott mechanical heart
valves1

1,000+ PEER-REVIEWED
PUBLICATIONS
provide evidence for Abbott mechanical
heart valves2

The range of types and sizes of our Regent™ and Masters Series Valves means you can choose precisely the valve that's best for your patients; from pediatrics to adults. Patients may have questions about medications and how this option compares with tissue valves. Use our patient guide to help you talk with your patients about mechanical heart valves.
 

Download Guide

For people 60 years old and younger, a recent, large, multi-center study showed that mechanical heart valves lead to:

BETTER
SURVIVAL3

FEWER REOPERATIONS4

Hear how our mechanical heart valves have impacted patients lives

Patient-Allen

Allen

Patient-Veronika

Veronika

Patient-Colby

Colby

Patient-Javier

Javier

MHV Patient Sadie

Addressing an unmet need for high-risk pediatric patients

Meet Sadie, a recipient of the world’s smallest 15 mm pediatric mechanical heart valve. Diagnosed with a heart condition before birth, Sadie received Abbott’s Masters HP valve, which is the only pediatric mechanical heart valve of its size available. This valve was developed to address an unmet need for high-risk pediatric patients who previously had limited options. These patients are often younger than 1 year old, have complex heart defects, have undergone multiple prior heart surgeries, and ultimately require a valve replacement.

    Intelligent design. Trusted technology.

    CLINICAL DATA


    See the latest clinical data for Regent and Masters Series.
     

    see clinical data

    MAT-2010286 v9.0 | Item approved for U.S. use only.

    References
    1. Sales data on file at Abbott.
    2. Published paper list on file at Abbott.
    3. Bowdish M. et al. (2025). Bioprosthetic vs mechanical aortic valve replacement in patients 40 to 75 years of age. Journal of the American College of Cardiology, 85(12), 1289–1298. doi.org/10.1016/j.jacc.2025.01.013
    4. Feirer, Nina et al. Mechanical versus biological mitral valve replacement: Insights from prospensity score matching on survival and reoperation rates. The Journal of Thoracic and Cardiovascular Surgery, Volume 169, Issue 6, 1717-1727
    5. Internal testing performed, data on file at Abbott
    6. Shipkowitz T, Ambrus J, Kurk J, et al. Evaluation technique for bileaflet mechanical valves. J Heart Valve Dis. 2002;11(2):275-82
    Important Safety Information
    • Regent
    • MASTERS SERIES

    • Rx Only

      REGENT™ MECHANICAL HEART VALVE

      INDICATION FOR USE

      The SJM Regent™ Mechanical Heart Valve is intended for use as a replacement valve in patients with a diseased, damaged, or malfunctioning aortic valve. This device may also be used to replace a previously implanted aortic prosthetic valve.

      CONTRAINDICATIONS

      The SJM Regent™ Mechanical Heart Valve is contraindicated for individuals unable to tolerate anticoagulation therapy.

      POTENTIAL ADVERSE EVENTS

      Complications are associated with replacement mechanical heart valves include, but are not limited to, hemolysis, infections, thrombus, or thromboembolism, valve dehiscence, unacceptable hemodynamic performance, hemorrhagic complications secondary to anticoagulation therapy, prosthetic failure, heart failure or death. Any of these complications may require reoperation or explantation of the device.

    • Rx Only

      MASTERS SERIES MECHANICAL HEART VALVE

      INDICATION FOR USE

      The SJM™ Masters Series Mechanical Heart Valve is intended for use as a replacement valve in patients with a diseased, damaged, or malfunctioning aortic or mitral heart valve. This device may also be used to replace a previously implanted mitral or aortic prosthetic valve.

      CONTRAINDICATIONS

      The SJM™ Masters Series Mechanical Heart Valve is contraindicated for individuals unable to tolerate anticoagulation therapy.

      POTENTIAL ADVERSE EVENTS

      Complications associated with replacement mechanical heart valves include, but are not limited to, hemolysis, infections, thrombus, or thromboembolism, valve dehiscence, unacceptable hemodynamic performance, hemorrhagic complications secondary to anticoagulation therapy, prosthetic failure, failure or death. Any of these complications may require reoperation or explantation of the device.

    YOU ARE ABOUT TO ENTER AN ABBOTT COUNTRY OR REGION SPECIFIC WEBSITE.

    Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of the product that are not approved in other countries or regions.

    U.S. VISITOR INTERNATIONAL VISITOR

    YOU ARE ABOUT TO LEAVE
    www.structural­heart.abbott

    You are now leaving www.structuralheart.abbott. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

    OkCancel
    +